The case illustrates the enormous challenges that victims of the opioid crisis have had in getting compensation from the pharmaceutical industry, despite its pledge of billions of dollars to state and local governments.
Category: Opioids and Opiates
-
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addiction
The New York Times – Business: -
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Conclude
The New York Times – Business:The overdose reversal drug has been administered mostly by emergency responders and outreach workers. If the agency approves a nonprescription version, it could become as easily available as aspirin.
-
Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisis
The New York Times – Business:Investigators said the pharmaceutical manufacturer, one of the nation’s largest, had knowingly distributed opioids that were later resold illegally.
-
Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuits Nationwide
The New York Times – Business:The money would help pay for addiction treatment and drug education programs in communities across the United States.
-
Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Finds
The New York Times – Business:The analysis of 15 years of prescription data showed that the racial disparities are widening.
-
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases
The New York Times – Business:The agreement would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on for it to take effect.
-
Biden Administration to Offer Plan to Get Addiction-Fighting Medicine to Pregnant Women
The New York Times – Business:Pregnant women are more likely to die of a drug overdose than the average woman of childbearing age, but less likely to be accepted for medication-based treatment.
